Eagle Pharmaceuticals, Inc. Current Assets
Eagle Pharmaceuticals, Inc. had Current Assets of $187.25 million as of 2023-06-30, per its 10-Q/A filed 2023-08-09.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2023-08-09
- 2023-06-30: Assets, Current $187.25M.
- 2023-03-31: Assets, Current $192.49M.
- 2022-12-31: Assets, Current $188.75M.
- 2022-09-30: Assets, Current $185.05M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2023-06-30 | $187.25M 10-Q/A · filed 2023-08-09 | |
| 2023-03-31 | $192.49M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $188.75M 10-Q/A · filed 2023-08-09 | |
| 2022-09-30 | $185.05M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $194.46M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $240.17M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $172.61M 10-K · filed 2023-03-23 | |
| 2021-09-30 | $171.69M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $175.50M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $163.99M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $166.06M 10-K · filed 2022-03-08 | |
| 2020-09-30 | $163.80M 10-Q · filed 2020-11-02 | |
| 2020-06-30 | $168.44M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $275.57M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $179.45M 10-K · filed 2021-03-05 | |
| 2019-09-30 | $179.79M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $185.66M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $182.23M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $163.84M 10-K · filed 2020-03-02 | |
| 2018-09-30 | $197.77M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $201.60M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $168.82M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $188.70M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $182.15M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $123.87M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $123.57M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $109.11M 10-K · filed 2018-02-26 | |
| 2016-09-30 | $119.05M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $135.50M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $114.62M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $122.26M 10-K · filed 2017-03-15 | |
| 2015-09-30 | $120.30M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $120.55M 10-Q · filed 2015-08-11 | |
| 2015-03-31 | $129.79M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $49.71M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $53.02M 10-K · filed 2016-02-29 | |
| 2014-06-30 | $57.76M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $63.53M 10-Q · filed 2014-05-15 | |
| 2013-09-30 | $17.48M 10-K · filed 2014-12-22 | $17.48M 10-Q · filed 2014-05-15 |